Literature DB >> 24165769

Computed tomography screening for lung cancer: where are we now?

Jared D Christensen1, Betty C Tong.   

Abstract

Low-dose computed tomography (LDCT) screening has been shown to result in detection of earlier-stage lung cancers, with a 20% reduction in cancer-related deaths. LDCT screening offers significant potential benefits to selected patients; however, many questions remain, including questions about the applicability of lung cancer screening in clinical practice.

Entities:  

Mesh：

Year:  2013        PMID： 24165769      PMCID： PMC4089879     

Source DB:  PubMed          Journal:  N C Med J        ISSN： 0029-2559


  22 in total

1.  Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study.

Authors:  R Hubbard; A Venn; S Lewis; J Britton
Journal:  Am J Respir Crit Care Med       Date:  2000-01       Impact factor: 21.405

2.  The global burden of disease due to occupational carcinogens.

Authors:  Timothy Driscoll; Deborah Imel Nelson; Kyle Steenland; James Leigh; Marisol Concha-Barrientos; Marilyn Fingerhut; Annette Prüss-Ustün
Journal:  Am J Ind Med       Date:  2005-12       Impact factor: 2.214

3.  Survival of patients with stage I lung cancer detected on CT screening.

Authors:  Claudia I Henschke; David F Yankelevitz; Daniel M Libby; Mark W Pasmantier; James P Smith; Olli S Miettinen
Journal:  N Engl J Med       Date:  2006-10-26       Impact factor: 91.245

4.  Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy.

Authors:  W C Black; H G Welch
Journal:  N Engl J Med       Date:  1993-04-29       Impact factor: 91.245

5.  Thoracoscopic lobectomy facilitates the delivery of chemotherapy after resection for lung cancer.

Authors:  Rebecca P Petersen; DuyKhanh Pham; William R Burfeind; Steven I Hanish; Eric M Toloza; David H Harpole; Thomas A D'Amico
Journal:  Ann Thorac Surg       Date:  2007-04       Impact factor: 4.330

6.  Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON).

Authors:  Carola A van Iersel; Harry J de Koning; Gerrit Draisma; Willem P T M Mali; Ernst Th Scholten; Kristiaan Nackaerts; Mathias Prokop; J Dik F Habbema; Mathijs Oudkerk; Rob J van Klaveren
Journal:  Int J Cancer       Date:  2007-02-15       Impact factor: 7.396

Review 7.  Lung cancer in never smokers: a review.

Authors:  Janakiraman Subramanian; Ramaswamy Govindan
Journal:  J Clin Oncol       Date:  2007-02-10       Impact factor: 44.544

8.  The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer.

Authors:  A R Feinstein; D M Sosin; C K Wells
Journal:  N Engl J Med       Date:  1985-06-20       Impact factor: 91.245

9.  Lung cancer in patients with head and neck cancer. Incidence and long-term survival.

Authors:  U Atabek; M A Mohit-Tabatabai; S Raina; B F Rush; K S Dasmahapatra
Journal:  Am J Surg       Date:  1987-10       Impact factor: 2.565

10.  Results of initial low-dose computed tomographic screening for lung cancer.

Authors:  Timothy R Church; William C Black; Denise R Aberle; Christine D Berg; Kathy L Clingan; Fenghai Duan; Richard M Fagerstrom; Ilana F Gareen; David S Gierada; Gordon C Jones; Irene Mahon; Pamela M Marcus; JoRean D Sicks; Amanda Jain; Sarah Baum
Journal:  N Engl J Med       Date:  2013-05-23       Impact factor: 91.245
View more
  1 in total

1.  Circulating microvesicles and exosomes in small cell lung cancer by quantitative proteomics.

Authors:  Shona Pedersen; Katrine Papendick Jensen; Bent Honoré; Søren Risom Kristensen; Camilla Holm Pedersen; Weronika Maria Szejniuk; Raluca Georgiana Maltesen; Ursula Falkmer
Journal:  Clin Proteomics       Date:  2022-01-07       Impact factor: 3.988
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.